Low-lactose partially hydrolyzed infant formula
View Patent ↗The present invention relates to a low-lactose, partially hydrolyzed infant formula. The carbohydrate component of the infant formula comprises between 0% and 60% lactose and the protein component of the infant formula comprises partially hydrolyzed whey protein and casein, the protein component having a particular molecular weight.
1. An infant formula comprising:
a carbohydrate component which is comprised of between about 0% and 60% lactose, based on the total weight of the carbohydrates present in the infant formula; and
a protein component which is comprised of partially hydrolyzed whey protein and casein, wherein the ratio of whey protein to casein is between about 50:50 and 70:30 and wherein the protein hydrolysate has the peptides spread over the following range of molecular weight distribution as a function of their molar mass:
Molar Mass
% Molecular Weight
(in Daltons)
Distribution
<500
11-20
500-1000
25-38
1000-2000
27-30
2000-3000
8-16
3000-5000
3-10
>5000
2-11.
2. The infant formula according to claim 1 , wherein the protein hydrolysate has the peptides spread over the following molecular weight distribution as a function of their molar mass:
Molar Mass
% Molecular Weight
(in Daltons)
Distribution
<500
17
500-1000
35.1
1000-2000
30.9
2000-3000
9.6
3000-5000
4.2
>5000
2.8.
3. The infant formula according to claim 1 , wherein the ratio of whey protein:casein is about 60:40.
4. The infant formula according to claim 1 , wherein the carbohydrate component comprises between about 15% and 55% lactose.
5. The infant formula according to claim 1 , wherein the carbohydrate component comprises between about 20% and 30% lactose.
6. The infant formula according to claim 1 , wherein the carbohydrate component comprises about 25% weight percent lactose and about 75% weight percent corn syrup solids.
7. The infant formula according to claim 6 , wherein the degree of hydrolysis of the protein component is between about 6% and 9%.
8. The infant formula according to claim 1 , wherein the degree of hydrolysis of the protein component is between about 4% and 10%.
9. The infant formula according to claim 1 , wherein the infant formula additionally comprises at least one probiotic.
10. The infant formula according to claim 1 , wherein the infant formula additionally comprises at least one prebiotic.
11. The infant formula according to claim 10 , wherein the LCPUFA comprises DHA and ARA.
12. The infant formula according to claim 1 , wherein the infant formula additionally comprises a LCPUFA.
13. The infant formula according to claim 12 , wherein the LCPUFA comprises DHA or ARA.
14. The infant formula according to claim 12 , wherein the LCPUFA comprises DHA in an amount of between about 3 mg per kg of body weight per day to about 150 mg per kg of body weight per day.
15. The infant formula according to claim 12 , wherein the LCPUFA comprises ARA in an amount of between about 5 mg per kg of body weight per day to about 150 mg per kg of body weight per day.
16. The infant formula according to claim 15 , wherein the ratio of ARA:DHA is from about 1:3 to about 9:1.
17. The infant formula according to claim 15 , wherein the ratio of ARA:DHA is from about 1:2 to about 4:1.
18. The infant formula according to claim 15 , wherein the ratio of ARA:DHA is from about 2:3 to about 2:1
19. The infant formula according to claim 1 , wherein the infant formula is in powdered form.
20. The infant formula according to claim 1 , wherein the infant formula is in liquid form.
21. A method for preventing the onset of allergies in a subject, the method comprising administering to the subject an infant formula according to claim 1 .